Alfuzosin in Uretheric Stones - ALF-STONE
- Conditions
- retheric Stones
- Registration Number
- EUCTR2005-005481-36-PT
- Lead Sponsor
- Sanofi-Synthelabo Produtos Farmaceuticos, S.A.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Age 18 or more
Patients with imagiologic evidence of uretheric stones
Informed signed consent to participate in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Women pregnant or breast feeding
Patients with renal impairment (creatinine > 2mg/dl)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method